| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/24/2001 | CA2326550A1 Method for treating migraine symptoms |
| 05/24/2001 | CA2326549A1 Method for treating migraine symptoms with ibuprofen and salts thereof |
| 05/23/2001 | EP1101820A1 Pentraxin I and Pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/23/2001 | EP1101757A1 Heterocyclic compounds as tachykinin receptor antagonists |
| 05/23/2001 | EP1100967A2 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION |
| 05/23/2001 | EP1100961A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases |
| 05/23/2001 | EP1100958A2 Nucleic acid molecules with specific identification of native prp?sc , their production and the use thereof |
| 05/23/2001 | EP1100946A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates |
| 05/23/2001 | EP1100943A2 Herpesviral vectors for gene delivery |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100895A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100869A1 98 human secreted proteins |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100803A2 Pyrrolo 2,1-b] 1,3]benzothiazepines with atypical antipsychotic activity |
| 05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 05/23/2001 | EP1100797A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/23/2001 | EP1100796A1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100790A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 05/23/2001 | EP1100781A1 High affinity ligands for nociceptin receptor orl-1 |
| 05/23/2001 | EP1100780A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz f]indoles, a method for the production thereof, and their use as medicaments |
| 05/23/2001 | EP1100769A1 Aminomethylcarboxylic acid derivatives |
| 05/23/2001 | EP1100767A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 05/23/2001 | EP1100546A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| 05/23/2001 | EP1100532A2 Methods of using lanreotide, a somatostatin analogue |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100523A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100507A1 Antioxidant composition and method of treating diseases using same |
| 05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100501A1 Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
| 05/23/2001 | EP1100499A1 Prevention of migraine recurrence |
| 05/23/2001 | EP1100498A1 Heterocyclic sulphonamide derivatives |
| 05/23/2001 | EP1100497A1 Heterocyclyl sulphonamide derivatives |
| 05/23/2001 | EP1100483A2 Glucocorticoid-selective anti-inflammatory agents |
| 05/23/2001 | EP1100480A2 Cholinergic agents in the treatment of presbyopia |
| 05/23/2001 | EP1100472A1 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 05/23/2001 | EP1100471A1 Compressed compositions comprising clarified xanthan gum |
| 05/23/2001 | EP1100467A1 Method for making coated gabapentine or pregabaline particles |
| 05/23/2001 | EP1100465A1 Medicinal aerosol formulations |
| 05/23/2001 | EP0900218A4 Heterocyclic compounds |
| 05/23/2001 | EP0789709B1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 05/23/2001 | EP0788497B1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | CN1296529A Method for screening therapeutic agents |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296485A Substituted indolealkanoic acids |
| 05/23/2001 | CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 05/23/2001 | CN1296478A Histamine H3 receptor ligands |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1296471A Substituted 2-phenyl-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system and pharmaceutical compositions containing them |
| 05/23/2001 | CN1296409A Treatment of panic attacks |
| 05/23/2001 | CN1296010A Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 05/23/2001 | CN1295853A Novel medicine for stopping narcotic taking and preparation process thereof |
| 05/23/2001 | CN1295852A Medicinal composition for stopping narcotic taking and preparation process thereof |
| 05/23/2001 | CN1295844A Application of cephalanoplos for antagonizing harmful substance of cigarette |
| 05/23/2001 | CN1066145C N-substituted 3-azabicyclo (3,2,0) heptane derivatives and preparing method and use thereof |
| 05/23/2001 | CN1066135C Synthesized excitatory amino acid |
| 05/22/2001 | US6235970 CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235885 Central nervous system disorders |
| 05/22/2001 | US6235792 Phosphate salt of isopropyl-methyl- [2-(3-n-propoxyphenoxy)ethyl]amine |
| 05/22/2001 | US6235774 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration |
| 05/22/2001 | US6235765 Benzimidazole derivatives |
| 05/22/2001 | US6235760 Treatment for CNS injuries |
| 05/22/2001 | US6235758 Indole derivatives as 5-HT receptor antagonist |
| 05/22/2001 | US6235752 Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptors |
| 05/22/2001 | US6235750 Nitric oxide synthase inhibitor |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235738 Brain disorders; antiischemic agents |
| 05/22/2001 | US6235734 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| 05/22/2001 | US6235719 Controlling sleep cycle |
| 05/22/2001 | US6235527 Lineage restricted glial precursors from the central nervous system |
| 05/22/2001 | US6235497 Viral vector coding rodent transport protein; for treatment of nervous system disorders |
| 05/22/2001 | US6235289 Intraspinal methods for treating pain |
| 05/22/2001 | US6235287 Extract of curcuma amada plant and a compound selected from ocimene, dihydro-ocimene, piene/a-/, curcumene-alpha and beta, linalool, cuminyl alcohol, keto-alchol, turmerone, linalyl acetate, ssfrole, carene-3, myrcene, cineol, limonene |
| 05/22/2001 | CA2217006C Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 05/22/2001 | CA2216787C 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants |
| 05/22/2001 | CA2013380C Selective adenosine receptor agents |
| 05/17/2001 | WO2001035106A2 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034769A2 24 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034654A1 Hedgehog fusion proteins and uses |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034639A2 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 05/17/2001 | WO2001034631A2 PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |